Jan J. Melenhorst
- Oncology top 10%
- CAR-T cell therapy research 10
- Vascular Tumors and Angiosarcomas 1
-
- Biosimilars and Bioanalytical Methods 2
-
- Chronic Lymphocytic Leukemia Research 2
-
- Chronic Lymphocytic Leukemia Research 2
-
- Acute Lymphoblastic Leukemia research 3
-
- Lymphoma Diagnosis and Treatment 3
-
- Neuroblastoma Research and Treatments 2
-
- Childhood Cancer Survivors' Quality of Life 1
- Co-authors
- Simon F. LaceyCarl H. JuneBruce L. LevineDavid L. PorterKatherine T. MarcucciStephen J. SchusterStephan A. GruppGabriela Plesa
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- United StatesSwitzerland
In The Last Decade
Jan J. Melenhorst
10 papers receiving 306 citations
Peers
Comparison fields: 5 of 24
- Oncology 300
- Immunology 85
- Genetics 98
- Genetics 22
- Biomedical Engineering 74
Countries citing papers authored by Jan J. Melenhorst
This map shows the geographic impact of Jan J. Melenhorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan J. Melenhorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan J. Melenhorst more than expected).
Fields of papers citing papers by Jan J. Melenhorst
This network shows the impact of papers produced by Jan J. Melenhorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan J. Melenhorst. The network helps show where Jan J. Melenhorst may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jan J. Melenhorst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 5 | |
| 2 | 2017 | 15 | |
| 3 | 2016 | 28 | |
| 4 | 2016 | 30 | |
| 5 | 2016 | 36 | |
| 6 | 2015 | 35 | |
| 7 | 2015 | 45 | |
| 8 | 2015 | 60 | |
| 9 | 2015 | 32 | |
| 10 | 2014 | 30 |
About Jan J. Melenhorst
Jan J. Melenhorst is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine, having authored 10 papers that have together received 316 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Acute Lymphoblastic Leukemia research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Neuroblastoma Research and Treatments (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Vascular Tumors and Angiosarcomas (1 paper) and Childhood Cancer Survivors' Quality of Life (1 paper). The work is most often cited by research in Oncology (300 citations), Immunology (85 citations) and Genetics (98 citations). Jan J. Melenhorst has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Simon F. Lacey, Carl H. June, Bruce L. Levine, David L. Porter, Katherine T. Marcucci, Stephen J. Schuster, Stephan A. Grupp, Gabriela Plesa, Gregory L. Beatty and Pamela A. Shaw. Their work appears in journals such as Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.